Cong Xue
Overview
Explore the profile of Cong Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
1637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang R, Li H, Li S, Shu D, Chen R, Zheng Z, et al.
MedComm (2020)
. 2025 Mar;
6(3):e70124.
PMID: 40060196
This multicenter study aimed to investigate the efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy (ICI-Chemo group) versus chemotherapy alone (Chemo group) for patients with cancer of unknown primary (CUP)...
2.
Xue C, Yang W, Hu A, He C, Liao H, Chen M, et al.
BMC Cancer
. 2025 Mar;
25(1):410.
PMID: 40050768
Background: The plasma concentration of endoxifen, the active metabolite of tamoxifen, might be affected by different CYP2D6 genotypes in patients with breast cancer, but solid evidence is still lacking in...
3.
Zhou J, Zan M, Zhai L, Yang S, Xue C, Li R, et al.
Sci Rep
. 2025 Feb;
15(1):6187.
PMID: 39979476
Forest aboveground biomass (AGB) is a key indicator reflecting the function and quality of forest ecosystems, and accurate large-scale estimations of forest AGB are essential for effective forest ecosystem management....
4.
Huang R, Hu A, Rong Q, Shu D, Chen M, Yang W, et al.
J Transl Med
. 2025 Jan;
23(1):63.
PMID: 39806366
Background: HER2-targeted antibody-drug conjugates (ADCs) have revolutionized the treatment landscape of metastatic breast cancer. However, the efficacy of these therapies may be compromised by genomic alterations. Hence, this study aims...
5.
Hong R, Xu F, Xia W, Teng Y, Ouyang Q, Zheng Q, et al.
J Clin Oncol
. 2025 Jan;
:JCO2400938.
PMID: 39746176
Purpose: The effects of metronomic chemotherapy plus endocrine therapy have yet to be elucidated through a randomized phase III clinical trial. Methods: Randomized clinical trials were conducted at 12 centers...
6.
Yu L, Zhao Y, Zhang S, Xu L, Tang S, Geng Y, et al.
BMC Microbiol
. 2024 Dec;
24(1):544.
PMID: 39732665
Avian pathogenic Escherichia coli (APEC) is a significant pathogen infecting poultry that is responsible for high mortality, morbidity and severe economic losses to the poultry industry globally, posing a substantial...
7.
Yang S, Zan M, Yuan R, Chen Z, Kong J, Xue C, et al.
Huan Jing Ke Xue
. 2024 Dec;
46(1):378-387.
PMID: 39721643
Land use change is the main cause of carbon stock changes in terrestrial ecosystems. Studying the impact mechanisms of carbon stock changes in different land use types in the arid...
8.
Yu L, Zhao Y, Zhang S, Ni W, Zhang L, Xue C, et al.
BMC Microbiol
. 2024 Dec;
24(1):526.
PMID: 39695425
Multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) is currently recognized not only as a significant nosocomial pathogen but also is an emerging bacterial infection in food-producing animals, posing a critical threat...
9.
Xue C, Dai Y, Li G, Zhang Y
Discov Oncol
. 2024 Dec;
15(1):778.
PMID: 39692796
Background: The aim of this study is to integrate immune and metabolism-related genes in order to construct a predictive model for predicting the prognosis and treatment response of LUAD(lung adenocarcinoma)...
10.
Xue C, Liu B, Zhao Y, Wang X, Sun Z, Xie F, et al.
Neuroscience
. 2024 Nov;
563:63-73.
PMID: 39521319
Stress is an independent risk factor for cognitive impairment, with elevated plasma homocysteine (HCY) levels playing a crucial role in stress-induced cognitive decline. While the rise in plasma HCY levels...